Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3121–3144 of 3,928 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Sleep Apnea Syndromes
Interventions: Continuous positive airway pressure; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 30 Years to 70 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: BMS-823778, Placebo matching with BMS-823778; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 22
States / cities: Jonesboro, Arkansas • Los Angeles, California • Palm Springs, California + 18 more

Conditions: Cognitive Decline, Hypertension, Diet, Aerobic Exercise
Interventions: Enhanced Usual Care (EUC), Food Delivery and Cooking PLUS Aerobic Training (FoRKS+); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 35 Years to 75 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hypertension, High Blood Pressure, Ventricular Hypertrophy, Diastolic Dysfunction, Systolic Dysfunction
Interventions: Exercise, Weight Loss, Low Sodium Diet, Smoking Cessation, Pharmaceutical Therapy (no specific therapy; approach guided by the JNC 7 protocol guidelines); Behavioral · Drug
Lead sponsor: Wayne State University; Other
Eligibility: 35 Years to 75 Years
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Healthy Volunteers
Interventions: 13mg Bimatoprost Ocular Insert; Drug
Lead sponsor: ForSight Vision5, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Artesia, California

Conditions: Hypertension
Interventions: Enhanced health education, Transcendental Meditation program; Behavioral
Lead sponsor: Maharishi International University; Other
Eligibility: 40 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Kidney Diseases
Interventions: Placebo, KBP-5074; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 666 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 65
States / cities: Foley, Alabama • Huntsville, Alabama • Mesa, Arizona + 47 more

Conditions: Open-Angle Glaucoma, Ocular Hypertension
Interventions: bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2, bimatoprost 10 µg generation 2, bimatoprost 6 µg generation 2, bimatoprost 15 µg generation 1, bimatoprost 10 µg generation 1, bimatoprost 0.03%; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 36
States / cities: Artesia, California • La Jolla, California • Los Angeles, California + 31 more

Conditions: Pulmonary Arterial Hypertension
Interventions: Oral Treprostinil; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 12 Years and older
Enrollment: 894 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2020
U.S. locations: 61
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 46 more

Conditions: Risk Drinking,Diabetes, Hypertension, Osteoporosis, Infertility
Interventions: Brief Intervention, Diagnostic assessment; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 611 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Dietitian-Assisted DASH groceries, Self-directed shopping; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intracranial Pressure Increase
Interventions: Pictor; Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: Up to 21 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Primary Open Angle Glaucoma
Interventions: dietary supplement with antioxidants, Placebo; Dietary Supplement
Lead sponsor: ScienceBased Health; Industry
Eligibility: 30 Years to 70 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Thyroid Eye Disease, Ocular Hypertension, Glaucoma
Interventions: Prostaglandin Analog, Timolol; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Gestational Hypertension, Preeclampsia, Chronic Hypertension With Pre-Eclampsia Complicating Childbirth, HELLP Syndrome
Interventions: Home blood pressure monitoring; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older · Female only
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Charleston, South Carolina • Greenville, South Carolina

Conditions: Pulmonary Arterial Hypertension
Interventions: ubenimex, placebo; Drug · Other
Lead sponsor: Eiger BioPharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 28
States / cities: Birmingham, Alabama • Beverly Hills, California • La Jolla, California + 22 more

Conditions: Hypertension, Self-management, Technology, Community-based Participatory Research
Interventions: Coachman, Enhanced Usual Care (EUC); Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 30 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 17 Years to 90 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Glaucoma, Ocular Hypertension
Interventions: Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%, timolol maleate 0.5%, latanoprost 0.005%; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Hypertension
Interventions: Partial sleep deprivation (sleep restriction), Normal sleep; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 35 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypertension
Interventions: Effects of dark chocolate; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Glaucoma
Interventions: GDD, Amniotic Membrane Graft, Pericardial Graft; Procedure
Lead sponsor: BioTissue Holdings, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 4
States / cities: Miami, Florida • New York, New York

Conditions: Hypertension
Interventions: Multilevel Hypertension Care Model; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Medication Adherence, High Blood Pressure, Diabetes
Interventions: Comparison to peers, Adherence feedback, Electronic pill bottle; Behavioral · Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Race And CPAP Effectiveness

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

MIND Foods and Aerobic Training in Black Adults With HTN

Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients

Bimatoprost Ocular Insert Pharmacokinetic Study

Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension

Women's Health Habits Study

Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension

Ocular Screening in Children and Young Adults at Risk for Increased Intracranial Pressure

The Effects of an Antioxidant Formulation on Ocular Blood Flow

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement

Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

Sleep Restriction and Parental History of Hypertension

Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure

Shunt Tube Exposure Prevention Study

Optimizing Care For Management Of Hard To Control Hypertension In Low-Income Patients Across Family Health Centers In New York City

Social Forces to Improve Statin Adherence (Study B)